一个有机生物传感平台,用于对膀癌的个性化预后
Yue Yan1, Mona Ahmed1, Kathleen E Mach2
1Department of Biomedical Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.
ACS nano
|October 30, 2025
概括
这项研究引入了一个有机体生物传感平台,以评估化疗对膀癌的影响. 该系统评估患者特定的瘤入侵,为个性化膀癌治疗策略铺平了道路.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 膀癌经常复发和进展,需要有效的治疗.
- 化疗改善了结果,但有副作用,可以矛盾地增加瘤的侵入性.
- 个性化预后策略对于有效管理膀癌至关重要.
研究的目的:
- 开发和验证一种有机体生物传感平台,用于对膀癌中化疗诱导作用的患者特异性评估.
- 评估平台在预测化疗诱导入侵和指导个性化治疗方面的潜力.
主要方法:
- 使用患者衍生的膀瘤器官和微瘤,在仿生微环境中培养.
- 集成的活单细胞纳米生物传感器与3D时隔显微镜进行实时监测.
- 在个体患者层面上评估了西斯普拉丁诱导的膀癌器官的入侵.
主要成果:
- 器官生物传感平台成功地以患者特定的方式评估了化疗诱导的入侵.
- 实时检测分子生物标志物和评估瘤侵入性的实时检测.
- 提供了一种方法来调查化学疗法诱导侵袭的患者特异性风险.
结论:
- 器官生物传感系统为研究化疗诱导的膀癌侵袭提供了一种新的方法.
- 这项技术有可能指导膀癌患者的个性化治疗策略.
- 能够更好地了解化疗对个体患者层面上的瘤行为的影响.
相关概念视频
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863


